BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28017138)

  • 1. Sumoylation Pathway as Potential Therapeutic Targets in Cancer.
    Gong L; Qi R; Li DW
    Curr Mol Med; 2017; 16(10):900-905. PubMed ID: 28017138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation homeostasis in tumorigenesis.
    Xie M; Yu J; Ge S; Huang J; Fan X
    Cancer Lett; 2020 Jan; 469():301-309. PubMed ID: 31705931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation in Cellular Senescence and Aging.
    Gong L; Sun Q; Li DW
    Curr Mol Med; 2017; 16(10):871-876. PubMed ID: 28017139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation in carcinogenesis.
    Bettermann K; Benesch M; Weis S; Haybaeck J
    Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of SUMO in the Maintenance of Genome Stability.
    Zilio N; Eifler-Olivi K; Ulrich HD
    Adv Exp Med Biol; 2017; 963():51-87. PubMed ID: 28197906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of SUMO modification in the maintenance of genome stability].
    Synowiec E; Ksiazek D; Błasiak J; Woźniak K
    Postepy Biochem; 2008; 54(3):234-41. PubMed ID: 19112822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molecular Interface Between the SUMO and Ubiquitin Systems.
    Staudinger JL
    Adv Exp Med Biol; 2017; 963():99-110. PubMed ID: 28197908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO-targeted ubiquitin ligases.
    Sriramachandran AM; Dohmen RJ
    Biochim Biophys Acta; 2014 Jan; 1843(1):75-85. PubMed ID: 24018209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sites.
    Zhou L; Zheng L; Hu K; Wang X; Zhang R; Zou Y; Zhong L; Wang S; Wu Y; Kang T
    Signal Transduct Target Ther; 2020 Jun; 5(1):80. PubMed ID: 32576812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumoylation in Development and Differentiation.
    Deyrieux AF; Wilson VG
    Adv Exp Med Biol; 2017; 963():197-214. PubMed ID: 28197914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.
    He X; Riceberg J; Soucy T; Koenig E; Minissale J; Gallery M; Bernard H; Yang X; Liao H; Rabino C; Shah P; Xega K; Yan ZH; Sintchak M; Bradley J; Xu H; Duffey M; England D; Mizutani H; Hu Z; Guo J; Chau R; Dick LR; Brownell JE; Newcomb J; Langston S; Lightcap ES; Bence N; Pulukuri SM
    Nat Chem Biol; 2017 Nov; 13(11):1164-1171. PubMed ID: 28892090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the SUMO modification system is required for the accumulation of RAD51 at sites of DNA damage.
    Shima H; Suzuki H; Sun J; Kono K; Shi L; Kinomura A; Horikoshi Y; Ikura T; Ikura M; Kanaar R; Igarashi K; Saitoh H; Kurumizaka H; Tashiro S
    J Cell Sci; 2013 Nov; 126(Pt 22):5284-92. PubMed ID: 24046452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and Analysis of SUMOylation Substrates In Vitro and In Vivo.
    Cedeño C; La Monaca E; Esposito M; Gutierrez GJ
    Methods Mol Biol; 2016; 1449():267-78. PubMed ID: 27613042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ubiquitins, proteasomes, sumoylation and application today and in future for cancer and other diseases therapy II. Sumoylation and neddylation as posttranslational modifications of proteins and their ubiquitinylation and its significance].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Jun; 52(6):619-27. PubMed ID: 16871767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting synthetic lethal interactions between DNA damage signaling, checkpoint control, and p53 for targeted cancer therapy.
    Morandell S; Yaffe MB
    Prog Mol Biol Transl Sci; 2012; 110():289-314. PubMed ID: 22749150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylation: a regulatory protein modification in health and disease.
    Flotho A; Melchior F
    Annu Rev Biochem; 2013; 82():357-85. PubMed ID: 23746258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Cellular Processes by SUMO: Understudied Topics.
    Enserink JM
    Adv Exp Med Biol; 2017; 963():89-97. PubMed ID: 28197907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.
    Martins WC; Tasca CI; Cimarosti H
    Neurochem Res; 2016 Mar; 41(3):568-78. PubMed ID: 26227998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.